VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
+6.54%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$250M
AUM Growth
+$250M
(+2.4%)
Cap. Flow
+$23.7M
Cap. Flow
% of AUM
9.46%
Top 10 Holdings %
Top 10 Hldgs %
93.7%
Holding
23
New
3
Increased
3
Reduced
3
Closed
4
Top Buys
1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$37.9M |
2 |
argenx
ARGX
|
$13.6M |
3 |
Ascendis Pharma
ASND
|
$4.86M |
4 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$1.28M |
5 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$838K |
Top Sells
1 |
BioCryst Pharmaceuticals
BCRX
|
$20M |
2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$7.82M |
3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$2.97M |
4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.02M |
5 |
STML
Stemline Therapeutics, Inc.
STML
|
$1.95M |
Sector Composition
1 | Healthcare | 91.87% |